Zoetis has underperformed the healthcare sector over the past year, and analysts remain moderately optimistic about the stock’s outlook.
2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm
Why United Therapeutics (UTHR) Shares Are Sliding Today
United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates
United Therapeutics: Q4 Earnings Snapshot
United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced its financial results for the quarter and year ended December 31, 2025. Full year 2025 revenues...
United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For
United Therapeutics Corporation (Nasdaq: UTHR ) announced today that Michael Benkowitz , President and Chief Operating Officer, will provide a company overview...
United Therapeutics Corporation (Nasdaq: UTHR ) announced today that it will report its fourth quarter and full year 2025 financial results before the market opens on Wednesday, February...
A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack